Coherus BioSciences Inc (CHRS)
2.02
-0.16
(-7.34%)
USD |
NASDAQ |
Apr 24, 16:00
2.025
0.00 (0.00%)
After-Hours: 20:00
Coherus BioSciences Max Drawdown (5Y): 93.20% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 93.20% |
February 29, 2024 | 93.20% |
January 31, 2024 | 93.20% |
December 31, 2023 | 93.20% |
November 30, 2023 | 93.20% |
October 31, 2023 | 88.70% |
September 30, 2023 | 84.00% |
August 31, 2023 | 83.78% |
July 31, 2023 | 83.78% |
June 30, 2023 | 83.78% |
May 31, 2023 | 82.50% |
April 30, 2023 | 77.63% |
March 31, 2023 | 77.63% |
February 28, 2023 | 77.63% |
January 31, 2023 | 77.63% |
December 31, 2022 | 77.63% |
November 30, 2022 | 77.63% |
October 31, 2022 | 77.63% |
September 30, 2022 | 77.63% |
August 31, 2022 | 77.71% |
July 31, 2022 | 77.71% |
June 30, 2022 | 77.71% |
May 31, 2022 | 77.71% |
April 30, 2022 | 77.71% |
March 31, 2022 | 77.71% |
Date | Value |
---|---|
February 28, 2022 | 77.71% |
January 31, 2022 | 77.71% |
December 31, 2021 | 77.71% |
November 30, 2021 | 77.71% |
October 31, 2021 | 77.71% |
September 30, 2021 | 77.71% |
August 31, 2021 | 77.71% |
July 31, 2021 | 77.71% |
June 30, 2021 | 77.71% |
May 31, 2021 | 77.71% |
April 30, 2021 | 77.71% |
March 31, 2021 | 77.71% |
February 28, 2021 | 77.71% |
January 31, 2021 | 77.71% |
December 31, 2020 | 77.71% |
November 30, 2020 | 77.71% |
October 31, 2020 | 77.71% |
September 30, 2020 | 77.71% |
August 31, 2020 | 77.71% |
July 31, 2020 | 77.71% |
June 30, 2020 | 77.71% |
May 31, 2020 | 77.71% |
April 30, 2020 | 77.71% |
March 31, 2020 | 77.71% |
February 29, 2020 | 77.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
77.63%
Minimum
Sep 2022
93.20%
Maximum
Nov 2023
79.66%
Average
77.71%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
AbbVie Inc | 45.08% |
Inovio Pharmaceuticals Inc | 98.90% |
Nektar Therapeutics | 99.30% |
Avid Bioservices Inc | 86.42% |
Stereotaxis Inc | 86.04% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -38.52 |
Beta (5Y) | 0.5445 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.01% |
Historical Sharpe Ratio (5Y) | -0.4985 |
Historical Sortino (5Y) | -0.7915 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.93% |